marginally significantP = 0.08
Participants receiving AT showed marginally significant reductions in depressive symptom at week 1 (difference −0.49, 95% CI −1.02, 0.05, P = 0.08), week 2 (difference −0.54, 95% CI −1.09, 0.008, P = 0.05), week 3 (difference −0.50, 95% CI −1.10, 0.09, P = 0.10), and week 4 (difference −0.53, 95% CI −1.15, 0.08, P = 0.09) (Table S5 ).